Clinical Trials Browser

Phase 1/2 × Unknown × ribociclib × Clear all

NCT03913234 2022-05-10

Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer Patients

Phase 1/2 Unknown

Breast Neoplasms